IGM Biosciences Inc

IGM Biosciences Inc

IGMS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$77.5M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
IGM Biosciences IncIGM Biosciences Inc-0.4--53%0.6-
$-0.31

Current Fair Value

124.7% downside

Overvalued by 124.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$77.50 Million
Enterprise Value$49.25 Million
Earnings per Share$-3.24
Beta0.59
Outstanding Shares61,462,957

Return

Return on Equity-52.89%ROE
Return on Assets-49.90%
Return on Invested Capital-39.62%

Valuation & Multiples

P/E Ratio-0.39P/E Ratio
PEG0.13PEG
Price to Sales0.64Price to Sales
Price to Book Ratio1.27Price to Book Ratio
Enterprise Value to Revenue0.34
Enterprise Value to EBIT-1.23
Enterprise Value to Net Income-1
Total Debt to Enterprise0.05
Debt to Equity0.02Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 2.99%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %25.97%▼ 3.17%
Total Invested$17.88M▼ 12.76%
Investors Holding66▼ 14.00%

About IGM Biosciences Inc

IGM Biosciences Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.